A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients

Clinical trial NCT00903682 · COMPLETED

Trial details

NCT number: NCT00903682
Sponsor: Janssen-Cilag International NV
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HIV Infection HIV Acquired Immunodeficiency Syndrome

Start date: 2009-06-01
Primary completion: 2010-02-01
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.